Medicines: Apalutamide

Dr. Agarwal on the Tolerability of Apalutamide in mCSPC

Nonmetastatic CRPC: Considerations for Apalutamide

Apalutamide and the TITAN Clinical Trial

Targeted Oncology

Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC

Dr. Saad on Apalutamide Combination for Castration-Resistant Prostate Cancer

Dr. Saad on the Safety Profile of Apalutamide in M0CRPC

How is #apalutamide + standard treatment beneficial to patients with node-positive prostate cancer?

Doctor Grew Explains Cancer

Update: FDA Approves Apalutamide (Erleada) for Metastatic Castration-Sensitive Prostate Cancer

Prostate Cancer Research Institute

Synthesis of Drugs: Apalutamide

Named Reactions in Organic Chemistry

Apalutamide in Treating Nonmetastatic CRPC

This is SPARTAN! Apalutamide treatment for nmCRPC

Erleada or Apalutamide ADT Treatment

Living with Stage Four Metastatic Prostate Cancer

Considerations for Apalutamide Versus Enzalutamide in Prostate Cancer Treatment

Specialty Pharmacy Times

Dr. Saad on the Clinical Impact of Apalutamide in nmCRPC

Apalutamide Plus ADT Leads to Survival Benefit in mCSPC

Targeted Oncology

SPARTAN vs. PROSPER: apalutamide or enzalutamide for nmCRPC?

STARTAR: ADT with apalutamide, radiation therapy and docetaxel in prostate cancer

"Will adding apalutamide to my treatment improve my node-positive prostate cancer outcomes?"

Doctor Grew Explains Cancer

Live from ASCO: Apalutamide for Castration-Sensitive Prostate Cancer

Apalutamide for High-Risk Prostate Cancer | Learn About Clinical Trials

Prostate Cancer Research Institute